Literature DB >> 23778695

The impact of the Benign Brain Tumor Cancer Registries Amendment Act (Public Law 107-260) on non-malignant brain and central nervous system tumor incidence trends.

Bridget J McCarthy, Carol Kruchko, Therese A Dolecek.   

Abstract

The study objective was to investigate patterns of reported non-malignant brain and CNS tumor incidence over a time period encompassing 1997-2008 during which time the Benign Brain Tumor Cancer Registries Amendment Act (PL 107-260) was passed and implemented. Analyses of 75,350 incident non-malignant brain and CNS tumors from eleven population-based central registries revealed that there were statistically significant increases in the age-adjusted incidence rate for non-malignant tumors for those diagnosed prior to 2002 and over the time period from 2002 until 2005. However, no significant change in the age-adjusted incidence rate for non-malignant tumors was observed over the time period 2005 to 2008 indicating that the incidence from this time period may quantify the "true" incidence of non-malignant brain and CNS tumors in the United States.

Entities:  

Mesh:

Year:  2013        PMID: 23778695

Source DB:  PubMed          Journal:  J Registry Manag        ISSN: 1945-6131


  16 in total

1.  American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

Authors:  Quinn T Ostrom; Haley Gittleman; Peter M de Blank; Jonathan L Finlay; James G Gurney; Roberta McKean-Cowdin; Duncan S Stearns; Johannes E Wolff; Max Liu; Yingli Wolinsky; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2016-01       Impact factor: 12.300

2.  Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act.

Authors:  Therese A Dolecek; Emily Van Meter Dressler; Jigisha P Thakkar; Meng Liu; Abeer Al-Qaisi; John L Villano
Journal:  Cancer       Date:  2015-04-14       Impact factor: 6.860

3.  Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States.

Authors:  Varun R Kshettry; Quinn T Ostrom; Carol Kruchko; Ossama Al-Mefty; Gene H Barnett; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2015-05-24       Impact factor: 12.300

Review 4.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015.

Authors:  Quinn T Ostrom; Haley Gittleman; Gabrielle Truitt; Alexander Boscia; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2018-10-01       Impact factor: 12.300

5.  CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014.

Authors:  Quinn T Ostrom; Haley Gittleman; Peter Liao; Toni Vecchione-Koval; Yingli Wolinsky; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2017-11-06       Impact factor: 12.300

6.  Extracted magnetic resonance texture features discriminate between phenotypes and are associated with overall survival in glioblastoma multiforme patients.

Authors:  Ahmad Chaddad; Camel Tanougast
Journal:  Med Biol Eng Comput       Date:  2016-03-10       Impact factor: 2.602

7.  Defining future directions in spinal cord tumor research: proceedings from the National Institutes of Health workshop.

Authors:  Elizabeth B Claus; May Abdel-Wahab; Peter C Burger; Herbert H Engelhard; David W Ellison; Nicholas Gaiano; David H Gutmann; Daniel A Heck; Eric C Holland; George I Jallo; Carol Kruchko; Larry E Kun; Bernard L Maria; Zoran Rumboldt; Daniela Seminara; Giovanna M Spinella; Linda Stophel; Robert Wechsler-Reya; Margaret Wrensch; Richard J Gilbertson
Journal:  J Neurosurg Spine       Date:  2010-02

8.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.

Authors:  Quinn T Ostrom; Gino Cioffi; Haley Gittleman; Nirav Patil; Kristin Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2019-11-01       Impact factor: 12.300

9.  Years of life lived with disease and years of potential life lost in children who die of cancer in the United States, 2009.

Authors:  Peter M de Blank; Quinn T Ostrom; Chaturia Rouse; Yingli Wolinsky; Carol Kruchko; Joanne Salcido; Jill S Barnholtz-Sloan
Journal:  Cancer Med       Date:  2015-01-27       Impact factor: 4.452

10.  Incidence of Benign Meningiomas in the United States: Current and Future Trends.

Authors:  Sonia Bhala; Douglas R Stewart; Victoria Kennerley; Valentina I Petkov; Philip S Rosenberg; Ana F Best
Journal:  JNCI Cancer Spectr       Date:  2021-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.